Early induction of oxidative stress in a mouse model of Alzheimer's disease with heme oxygenase activity

Xing,Sanli; Shen,Dingzhu; Chen,Chuan; Wang,Jian; Yu,Zhihua

doi:10.3892/mmr.2014.2252

Early induction of oxidative stress in a mouse model of Alzheimer's disease with heme oxygenase activity

Authors:
- Sanli Xing
- Dingzhu Shen
- Chuan Chen
- Jian Wang
- Zhihua Yu
View Affiliations

Affiliations: Shanghai Geriatric Institute of Chinese Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai 200031, P.R. China
Published online on: May 20, 2014 https://doi.org/10.3892/mmr.2014.2252
Pages: 599-604
Copyright: © Xing et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY_NC 3.0].

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Evidence suggests that brain tissues of patients with Alzheimer's disease (AD) are easily attacked by oxidative stress, and numerous studies indicate that heme oxygenase (HO) is a major cell adaptive responder to stress. However, whether HO‑1 and HO‑2 play different roles in this process has not yet been studied. In the present study, it was shown in an AD model that HO‑1 and HO‑2 have different roles in the early stages of AD. Learning and memory ability was tested in APPswe/PS1ΔE9 (APP/PS1) transgenic and wild‑type mice using the Morris water maze. β‑amyloid plaques were measured using immunofluorescence staining. Changes in reactive oxygen species (ROS) levels in the hippocampi were measured using a fluorescence technique. The results indicated that the escape latency, amyloid plaque deposition and ROS production increased in the hippocampi of APP/PS1 transgenic mice compared with wild‑type mice. Furthermore, using double‑immunofluorescence staining and western blot analysis, it was found that the expression of HO‑1 and HO‑2 increased in the hippocampi of APP/PS1 mice and, notably, HO‑2 was also found to be overexpressed in astrocytes. Little difference was observed in the plasma HO‑1 concentrations between the two groups, while the plasma HO‑2 concentration of the APP/PS1 mice was lower than that of the wild‑type mice, shown by ELISA. In conclusion, HO‑2 overexpression is an early event and plays a more critical role in the progression of AD.

View Figures

View References

1	Sayre LM, Perry G and Smith MA: Oxidative stress and neurotoxicity. Chem Res Toxicol. 21:172–188. 2008. View Article : Google Scholar : PubMed/NCBI
2	Perrig WJ, Perrig P and Stähelin HB: The relation between antioxidants and memory performance in the old and very old. J Am Geriatr Soc. 45:718–724. 1997.PubMed/NCBI
3	Fujita K, Yamafuji M, Nakabeppu Y and Noda M: Therapeutic approach to neurodegenerative diseases by medical gases: focusing on redox signaling and related antioxidant enzymes. Oxid Med Cell Longev. 2012:3242562012. View Article : Google Scholar : PubMed/NCBI
4	Pae HO, Lee YC and Chung HT: Heme oxygenase-1 and carbon monoxide: emerging therapeutic targets in inflammation and allergy. Recent Pat Inflamm Allergy Drug Discov. 2:159–165. 2008. View Article : Google Scholar : PubMed/NCBI
5	Barañano DE and Snyder SH: Neural roles for heme oxygenase: contrasts to nitric oxide synthase. Proc Natl Acad Sci USA. 98:10996–11002. 2001.PubMed/NCBI
6	Schipper HM: Heme oxygenase expression in human central nervous system disorders. Free Radic Biol Med. 37:1995–2011. 2004. View Article : Google Scholar
7	Barone E, Di Domenico F, Sultana R, et al: Heme oxygenase-1 posttranslational modifications in the brain of subjects with Alzheimer disease and mild cognitive impairment. Free Radic Biol Med. 52:2292–2301. 2012. View Article : Google Scholar : PubMed/NCBI
8	Schipper HM, Song W, Zukor H, Hascalovici JR and Zeligman D: Heme oxygenase-1 and neurodegeneration: expanding frontiers of engagement. J Neurochem. 110:469–485. 2009. View Article : Google Scholar : PubMed/NCBI
9	Schipper HM, Cissé S and Stopa EG: Expression of heme oxygenase-1 in the senescent and Alzheimer-diseased brain. Ann Neurol. 37:758–768. 1995. View Article : Google Scholar : PubMed/NCBI
10	Schipper HM, Bennett DA, Liberman A, et al: Glial heme oxygenase-1 expression in Alzheimer disease and mild cognitive impairment. Neurobiol Aging. 27:252–261. 2006. View Article : Google Scholar : PubMed/NCBI
11	Su D, Zhao Y, Xu H, et al: Isoflurane exposure during mid-adulthood attenuates age-related spatial memory impairment in APP/PS1 transgenic mice. PLoS One. 7:e501722012. View Article : Google Scholar : PubMed/NCBI
12	Ghosh A, Sarkar S, Mandal AK and Das N: Neuroprotective role of nanoencapsulated quercetin in combating ischemia-reperfusion induced neuronal damage in young and aged rats. PLoS One. 8:e577352013. View Article : Google Scholar : PubMed/NCBI
13	Ishikawa M, Kajimura M, Adachi T, et al: Carbon monoxide from heme oxygenase-2 Is a tonic regulator against NO-dependent vasodilatation in the adult rat cerebral microcirculation. Circ Res. 97:e104–e114. 2005. View Article : Google Scholar
14	Vreman HJ, Wong RJ, Kadotani T and Stevenson DK: Determination of carbon monoxide (CO) in rodent tissue: effect of heme administration and environmental CO exposure. Anal Biochem. 341:280–289. 2005. View Article : Google Scholar : PubMed/NCBI
15	Feng Y and Wang X: Antioxidant therapies for Alzheimer’s disease. Oxid Med Cell Longev. 2012:4729322012.
16	Poon HF, Calabrese V, Scapagnini G and Butterfield DA: Free radicals and brain aging. Clin Geriatr Med. 20:329–359. 2004. View Article : Google Scholar : PubMed/NCBI
17	Mancuso M, Coppede F, Migliore L, Siciliano G and Murri L: Mitochondrial dysfunction, oxidative stress and neurodegeneration. J Alzheimers Dis. 10:59–73. 2006.PubMed/NCBI
18	Migliore L and Coppede F: Environmental-induced oxidative stress in neurodegenerative disorders and aging. Mutat Res. 674:73–84. 2009. View Article : Google Scholar : PubMed/NCBI
19	Moulton PV and Yang W: Air pollution, oxidative stress, and Alzheimer’s disease. J Environ Public Health. 2012:4727512012.
20	Adibhatla RM and Hatcher JF: Role of lipids in brain injury and diseases. Future Lipidol. 2:403–422. 2007. View Article : Google Scholar : PubMed/NCBI
21	Markesbery WR and Carney JM: Oxidative alterations in Alzheimer’s disease. Brain Pathol. 9:133–146. 1999.
22	Butterfield DA, Castegna A, Lauderback CM and Drake J: Evidence that amyloid beta-peptide-induced lipid peroxidation and its sequelae in Alzheimer’s disease brain contribute to neuronal death. Neurobiol Aging. 23:655–664. 2002.PubMed/NCBI
23	Cente M, Filipcik P, Pevalova M and Novak M: Expression of a truncated tau protein induces oxidative stress in a rodent model of tauopathy. Eur J Neurosci. 24:1085–1090. 2006. View Article : Google Scholar : PubMed/NCBI
24	Di Domenico F, Barone E, Mancuso C, et al: HO-1/BVR-a system analysis in plasma from probable Alzheimer’s disease and mild cognitive impairment subjects: a potential biochemical marker for the prediction of the disease. J Alzheimers Dis. 32:277–289. 2012.PubMed/NCBI
25	Butterfield DA, Barone E, Di Domenico F, et al: Atorvastatin treatment in a dog preclinical model of Alzheimer’s disease leads to up-regulation of haem oxygenase-1 and is associated with reduced oxidative stress in brain. Int J Neuropsychopharmacol. 15:981–987. 2012.PubMed/NCBI
26	Huang TC, Lu KT, Wo YY, Wu YJ and Yang YL: Resveratrol protects rats from Aβ-induced neurotoxicity by the reduction of iNOS expression and lipid peroxidation. PLoS One. 6:e291022011.
27	Hui Y, Wang D, Li W, et al: Long-term overexpression of heme oxygenase 1 promotes tau aggregation in mouse brain by inducing tau phosphorylation. J Alzheimers Dis. 26:299–313. 2011.PubMed/NCBI
28	Schipper HM: Brain iron deposition and the free radical-mitochondrial theory of ageing. Ageing Res Rev. 3:265–301. 2004. View Article : Google Scholar : PubMed/NCBI
29	Schipper HM, Chertkow H, Mehindate K, Frankel D, Melmed C and Bergman H: Evaluation of heme oxygenase-1 as a systemic biological marker of sporadic AD. Neurology. 54:1297–1304. 2000. View Article : Google Scholar : PubMed/NCBI
30	Yu HL, Chertkow HM, Bergman H and Schipper HM: Aberrant profiles of native and oxidized glycoproteins in Alzheimer plasma. Proteomics. 3:2240–2248. 2003. View Article : Google Scholar : PubMed/NCBI
31	Maes OC, Kravitz S, Mawal Y, et al: Characterization of alpha1-antitrypsin as a heme oxygenase-1 suppressor in Alzheimer plasma. Neurobiol Dis. 24:89–100. 2006. View Article : Google Scholar : PubMed/NCBI